Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma by Liz Hanson | Dec 1, 2021 | Uncategorized
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease by Liz Hanson | Nov 25, 2021 | Uncategorized
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial by Liz Hanson | Nov 10, 2021 | Uncategorized
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study by Liz Hanson | Sep 7, 2021 | Uncategorized
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma by Liz Hanson | Aug 18, 2021 | Uncategorized
